[HTML][HTML] Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations

FPM Cremers, W Lee, RWJ Collin… - Progress in retinal and eye …, 2020 - Elsevier
The ABCA4 protein (then called a “rim protein”) was first identified in 1978 in the rims and
incisures of rod photoreceptors. The corresponding gene, ABCA4, was cloned in 1997, and …

Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options

P Tanna, RW Strauss, K Fujinami… - British Journal of …, 2017 - bjo.bmj.com
Stargardt disease (STGD1; MIM 248200) is the most prevalent inherited macular dystrophy
and is associated with disease-causing sequence variants in the gene ABCA4. Significant …

Inherited retinal diseases: therapeutics, clinical trials and end points—a review

M Georgiou, K Fujinami… - Clinical & Experimental …, 2021 - Wiley Online Library
Inherited retinal diseases (IRDs) are a clinically and genetically heterogeneous group of
disorders characterised by photoreceptor degeneration or dysfunction. These disorders …

Progressive cone and cone-rod dystrophies: clinical features, molecular genetics and prospects for therapy

JS Gill, M Georgiou, A Kalitzeos, AT Moore… - British Journal of …, 2019 - bjo.bmj.com
Progressive cone and cone-rod dystrophies are a clinically and genetically heterogeneous
group of inherited retinal diseases characterised by cone photoreceptor degeneration …

Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod …

M Georgiou, AG Robson, K Fujinami… - Progress in retinal and …, 2024 - Elsevier
Inherited retinal diseases (IRD) are a leading cause of blindness in the working age
population and children. The scope of this review is to familiarise clinicians and scientists …

Gene therapy in inherited retinal diseases: an update on current state of the art

A Amato, A Arrigo, E Aragona, MP Manitto… - Frontiers in …, 2021 - frontiersin.org
Background: Gene therapy cannot be yet considered a far perspective, but a tangible
therapeutic option in the field of retinal diseases. Although still confined in experimental …

[HTML][HTML] Clinical and molecular characteristics of childhood-onset Stargardt disease

K Fujinami, J Zernant, RK Chana, GA Wright… - Ophthalmology, 2015 - Elsevier
Purpose To describe the clinical and molecular characteristics of patients with childhood-
onset Stargardt disease (STGD). Design Retrospective case series. Participants Forty-two …

In Silico Functional Meta‐Analysis of 5,962 ABCA4 Variants in 3,928 Retinal Dystrophy Cases

SS Cornelis, NM Bax, J Zernant, R Allikmets… - Human …, 2017 - Wiley Online Library
Variants in the ABCA4 gene are associated with a spectrum of inherited retinal diseases
(IRDs), most prominently with autosomal recessive (ar) Stargardt disease (STGD1) and ar …

Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options

N Rahman, M Georgiou, KN Khan… - British Journal of …, 2020 - bjo.bmj.com
Macular dystrophies (MDs) consist of a heterogeneous group of disorders that are
characterised by bilateral symmetrical central visual loss. Advances in genetic testing over …

A phase I clinical trial of human embryonic stem cell‐derived retinal pigment epithelial cells for early‐stage Stargardt macular degeneration: 5‐years' follow‐up

SY Li, Y Liu, L Wang, F Wang, TT Zhao, QY Li… - Cell …, 2021 - Wiley Online Library
Objectives To evaluate the long‐term biosafety and efficacy of transplantation of human
embryonic stem cells‐derived retinal pigment epithelial (hESC‐RPE) cells in early‐stage of …